Stablix Therapeutics is Drug Discovery in United States that focus on small-molecules that business. They cover business area such as operator, target protein stabilization, disease, technology, heterobifunctional small-molecule, deubiquitinase, protein function, healthcare professional, cancer, immunological disorder.
-
Small-molecules That
-
3960 Broadway
6th Floor
New York, NY 10032
United States
Private
operatortarget protein stabilizationdiseasetechnologyheterobifunctional small-moleculedeubiquitinaseprotein functionhealthcare professionalcancerimmunological disorder
* We use standard office opening hours in near Stablix Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Stablix Therapeutics is Drug Discovery business from United States that founded in - ( years old in ), Stablix Therapeutics business is focusing on Small-molecules That.
Stablix Therapeutics headquarter office and corporate office address is located in 3960 Broadway 6th Floor New York, NY 10032 United States.
Stablix Therapeutics was founded in United States.
In , Stablix Therapeutics is currently focus on small-molecules that sector.
Above is snippet of Google Trends for "small-molecules that" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Stablix Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
